PPARA and Hypertension: When the three CETP inhibitors are docked as agonists to these nuclear hormone receptors the stronger binding affinity to the panel of positive regulators (PPAR, LXR and RXR) indicates stronger up-regulation of RAAS and higher risk of hypertension; stronger binding affinity to the negative regulator VDR implies a lower risk of hypertension.